<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>The only randomized data on <z:chebi fb="5" ids="28304">heparin</z:chebi> treatment in <z:hpo ids='HP_0011009'>acute</z:hpo> cerebral sinus <z:hpo ids='HP_0004936'>venous thrombosis</z:hpo> (CSVT) are derived from a small number of patients </plain></SENT>
<SENT sid="1" pm="."><plain>The rate of <z:hpo ids='HP_0002170'>intracranial hemorrhages</z:hpo> as a complication of high-dose <z:chebi fb="5" ids="28304">heparin</z:chebi> treatment is still unknown </plain></SENT>
<SENT sid="2" pm="."><plain>This retrospective study evaluates the clinical features, neuroimaging monitoring and outcome of 42 patients with proven CSVT </plain></SENT>
<SENT sid="3" pm="."><plain>Diagnosis was established by DSA, CT, <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MR</z:e> tomography and <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MR</z:e> angiography </plain></SENT>
<SENT sid="4" pm="."><plain><z:hpo ids='HP_0000001'>All</z:hpo> patients received <z:chebi fb="5" ids="28304">heparin</z:chebi> intravenously guided by doubling the aPTT value for 3 weeks, followed by oral anticoagulation </plain></SENT>
<SENT sid="5" pm="."><plain>Partial or complete recanalization was found in 36 cases </plain></SENT>
<SENT sid="6" pm="."><plain>40 patients improved clinically, in 26 of them complete recovery was observed </plain></SENT>
<SENT sid="7" pm="."><plain>One patient deteriorated and developed an <z:e sem="disease" ids="C0854369" disease_type="Mental or Behavioral Dysfunction" abbrv="">apallic syndrome</z:e>, one further patient died of septic multiorgan failure </plain></SENT>
<SENT sid="8" pm="."><plain>Only in one patient was hemorrhagic transformation of infarcted brain tissue observed but without clinical deterioration </plain></SENT>
</text></document>